February 9, 2021 | Compliance An Analysis Of MHRA’s Latest Annual GMP Inspection Deficiencies Report Are you aware of recent changes from EMA pertaining to manufacturers of chemically synthesized drugs and biological products? Barbara Unger Principal Consultant 10 Minute Read
December 19, 2018 | Press Releases GHO Capital Acquires Validant, a Leading Quality, Compliance and Regulatory Affairs Consulting Firm for Healthcare Companies Carla Nieser 2 Minute Read
December 16, 2018 | Compliance EU MDR/IVDR Compliance: A Road Map for Success Stephanie Colotti Senior Partner, Validant 1 Minute Read